Sector
PharmaceuticalsOpen
₹61.1Prev. Close
₹62.45Turnover(Lac.)
₹4.47Day's High
₹62.45Day's Low
₹60.6552 Week's High
₹107.7952 Week's Low
₹51Book Value
₹15.75Face Value
₹10Mkt Cap (₹ Cr.)
373.57P/E
82.72EPS
0.74Divi. Yield
021 Apr 2025
12:00 AM
Board Meeting
Agenda : Audited Result
23 Aug 2024
12:00 AM
AGM
Announcement Date: 23 Aug, 2024
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 61.03 | 61.03 | 61.03 | 61.03 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 35.1 | 29.51 | 21.24 | 9.61 |
Net Worth | 96.13 | 90.54 | 82.27 | 70.64 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Revenue | 22.44 | 25.93 | 11.14 | 2.25 |
yoy growth (%) | -13.46 | 132.75 | 394.37 | 9.43 |
Raw materials | -0.03 | -0.5 | -0.79 | -1.66 |
As % of sales | 0.14 | 1.94 | 7.16 | 74.03 |
Employee costs | -6.49 | -5.76 | -5.06 | -3.02 |
| Y/e 31 Mar( In .Cr) | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Profit before tax | -1.21 | 4.4 | -11.85 | -21.69 |
Depreciation | -6.45 | -4.84 | -3.9 | -3.87 |
Tax paid | 0 | 0 | 0 | 0 |
Working capital | 0.71 | -0.28 | 52.29 | -18.35 |
Other operating items |
| Y/e 31 Mar | Mar-2021 | Mar-2020 | Mar-2018 | Mar-2017 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | -13.46 | 132.75 | 394.37 | 9.43 |
Op profit growth | -28.29 | -213.09 | -24.38 | 35.6 |
EBIT growth | -93.72 | -156.37 | -33.78 | 22.48 |
Net profit growth | -111.27 | -190.94 | -40.35 | 3.82 |
| Particulars (Rupees in Crores.) | Mar-2010 | Mar-2009 | Mar-2008 | Mar-2007 | Mar-2006 |
|---|---|---|---|---|---|
Gross Sales | 6.57 | 6.01 | 8.22 | 13.46 | 13.19 |
Excise Duty | 0 | 0 | 0 | 0.62 | 0.82 |
Net Sales | 6.57 | 6.01 | 8.22 | 12.82 | 12.36 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 2.1 | 4.63 | 2.17 | 9.31 | 0.09 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,663.15 | 93.33 | 3,99,045.4 | 2,000.46 | 0.96 | 7,107.14 | 101.44 |
Divis Laboratories Ltd DIVISLAB | 6,841.15 | 82.22 | 1,81,611.04 | 667 | 0.44 | 2,536 | 561.08 |
Cipla Ltd CIPLA | 1,477.3 | 24.79 | 1,19,322.68 | 1,485.4 | 1.08 | 4,254.47 | 397.41 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,339.05 | 59.72 | 1,13,003.55 | 474 | 0.18 | 2,385 | 224.34 |
Dr Reddys Laboratories Ltd DRREDDY | 1,259.2 | 19.53 | 1,05,090.54 | 1,200.7 | 0.63 | 5,546.3 | 345.76 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Non Executive Director
Jignesh Anantray Goradia
Chairman (Non-Executive)
Azadar Hussain Khan
Independent Director
Chintan Jitendra Shah
Company Sec. & Compli. Officer
Abdul Gafoor Mohammad
Independent Director
JAGRUTI PRASHANT SHETH
Non Executive Director
Rakeshchandra Jagdishprasad Sinha
Additional Director
Premal Hemant Gandhi
S No 250-252 Turkapally Villag,
Shameerpet Mandal RR District,
Telangana - 500078
Tel: 91-40-23480430/0435
Website: http://www.zenotechlab.com
Email: abdul.gafoor@zenotech.co.in
Karvy Selenium Tow-B,
31&32 Financial Dist, Nanakramguda,
Hyderabad-500032
Tel: 91-40-67162222
Website: www.kfintech.com
Email: einward.ris@kfintech.com
Summary
Zenotech Laboratories Limited (Formerly Sunline Technologies Limited) was established in June, 1989 and changed to its present name effective on August 9, 2004. The Company is a pharmaceutical special...
Read More
Reports by Zenotech Laboratories Ltd
What is the Zenotech Laboratories Ltd share price today?
What is the Market Cap of Zenotech Laboratories Ltd?
What is the PE and PB ratio of Zenotech Laboratories Ltd?
What is the 52 Week High and Low of Zenotech Laboratories Ltd?
What is the CAGR of Zenotech Laboratories Ltd?
What is the shareholding pattern of Zenotech Laboratories Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.